NCT03006952View on ClinicalTrials.gov

Add-on Pentoxifylline to Losartan Versus Increasing Dose of Losartan on NT-PRO BNP in Type 2 Diabetics With Nephropathy

PHASE4CompletedINTERVENTIONAL
Enrollment

59

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

September 30, 2015

Study Completion Date

September 30, 2015

Conditions
Diabetic Nephropathies
Interventions
DRUG

Pentoxifylline

pentoxifylline arm took 400 mg pentoxifylline twice daily plus 50mg losartan daily for 12 weeks.

DRUG

Losartan

losartan arm took 100mg losartan daily for 12 weeks.

Trial Locations (1)

Unknown

Tehran University of Medical Sciences, Tehran

All Listed Sponsors
lead

Tehran University of Medical Sciences

OTHER

NCT03006952 - Add-on Pentoxifylline to Losartan Versus Increasing Dose of Losartan on NT-PRO BNP in Type 2 Diabetics With Nephropathy | Biotech Hunter | Biotech Hunter